Baclofen dosage after traumatic spinal cord injury: A multi-decade retrospective analysis

Clinical Neurology and Neurosurgery

Volumn 129, Issue , 2014, Pages 50-56

  Veerakumar, Ashan ^a   Cheng, Jennifer J ^b   Sunshine, Abraham ^b   Ye, Xiaobu ^b   Zorowitz, Richard D ^c   Anderson, William S ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Baclofen; Paralysis; Spasticity; Spinal cord injury

Indexed keywords

BACLOFEN; DIAZEPAM; TIZANIDINE; CENTRAL MUSCLE RELAXANT;

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL SPINAL CORD; CHILD; CHILDHOOD INJURY; COHORT ANALYSIS; DIVING; DRUG DOSE INCREASE; FEMALE; GUNSHOT INJURY; HUMAN; LUMBAR SPINAL CORD; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OCCUPATIONAL ACCIDENT; PRESCRIPTION; RETROSPECTIVE STUDY; SPASTICITY; SPINAL CORD INJURY; SPORT INJURY; SURVIVAL RATE; SURVIVAL TIME; SWIMMING; THORAX INJURY; TRAFFIC ACCIDENT; WORKPLACE; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; MUSCLE SPASTICITY; PROCEDURES; SPINAL CORD INJURIES; WOUNDS, GUNSHOT; YOUNG ADULT;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGED; BACLOFEN; CHILD; COHORT STUDIES; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; WOUNDS, GUNSHOT; YOUNG ADULT;

EID: 84919668250     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2014.11.023     Document Type: Article

References (25)

1. M.E.L. Van den Berg, J.M. Castellote, I. Mahillo-Fernandez, and J. de Pedro-Cuesta Incidence of spinal cord injury worldwide: a systematic review Neuroepidemiology 34 2010 184 192
2. National Spinal Cord Injury Statistical Center Spinal cord injury facts and figures at a glance J Spinal Cord Med 36 1 2013 1 2
3. A.J. Schoenfeld, B. McCriskin, M. Hsiao, and R. Burks Incidence and epidemiology of spinal cord injury within a closed American population: the United States military (2000-2009) Spinal Cord 49 2011 874 879
4. R. Levi, C. Hultling, M.S. Nash, and A. Seiger The stockholm spinal cord injury study: 1. Medical problems in a regional SCI population Paraplegia 33 1995 308 315
5. P. Daverat, H. Petit, G. Kemoun, J.F. Dartigues, and M. Barat The long term outcome in 149 patients with spinal cord injury Paraplegia 33 1995 665 668
6. F.M. Maynard, R.S. Karunas, and W.P. Waring 3rd Epidemiology of spasticity following traumatic spinal cord injury Arch Phys Med Rehabil 71 8 1990 566 569
7. C. Sköld, R. Levi, and A. Seiger Spasticity after traumatic spinal cord injury: nature, severity, and location Arch Phys Med Rehabil 80 1999 1548 1557
8. J.W. Lance Symposium synopsis R.G. Feldmann, R.R. Young, W.P. Koella, Spasticity: disordered motor control 1980 Year Book Medical Publishers Chicago 485 495
9. R.R. Young, and B.T. Shahani Spasticity in spinal cord injured patients Management of spinal cord injuries 1986 Williams and Wilkins Baltimore 241 283
10. A. Priori, F. Cogiamanian, and S. Mrakic-Sposta Pathophysiology of spasticity Neurol Sci 27 2006 S307 S309
11. T. Hagg, and M. Oudega Degenerative and spontaneous regenerative processes after spinal cord injury J Neurotrauma 23 3-4 2006 263 280
12. Benefits and challenges of spasticity A.M. Bakheit "The pharmacological management of post-stroke muscle spasticity." Drugs Aging 29 12 2012 941 947
13. M. Wirz, C. Bastiaenen, R. de Bie, and V. Dietz Effectiveness of automated locomotor training in patients with acute incomplete spinal cord injury: a randomized controlled multicenter trial BMC Neurol 11 1 2011 60
14. J.M. D'Amico, E.G. Condliffe, K.J. Martins, D.J. Bennett, and M.A. Gorassini Recovery of neuronal and network excitability after spinal cord injury and implications for spasticity Front Integr Neurosci 8 2014
15. N.G. Bowery GABAB receptor: a site of therapeutic benefit Curr Opin Pharmacol 6 1 2006 37 43
16. U.S. Food and Drug Administration Kemstro (baclofen) tablets printed labeling. PDF file 2003 Available from http://www.accessdata.fda.gov/drugsatfda-docs/nda/2003/021589s000-KemstroTOC.cfm. [accessed 14.08.14]
17. A. Kedhar, K. Padmakumari, and S. Nair Spasticity: pathophysiology Eval Manag Pract Neurol 12 5 2012 289 298
18. National Spinal Cord Injury Statistical Center Annual NSCISC Annual Statistical Report - Complete Public Version. PDF File. November 2012 2012 Available from www.uab.edu/nscisc [accessed 24.03.14]
19. N. Draulans, K. Vermeersch, B. Degraeuwe, T. Meurrens, K. Peers, and B. Nuttin Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution Clin Rehabil 27 12 2013 1137 1143
20. I. Dones, and G. Broggi A case of very long-term appearing drug tolerance to intrathecal baclofen J Neurosurg Sci 54 2 2010 77 78
21. M. Oshiro, M.P. Hefferan, O. Kakinohana, N. Lukacova, K. Sugahara, and T.L. Yaksh Suppression of stretch reflex activity after spinal or systemic treatment with AMPA receptor antagonist NGX424 in rats with developed baclofen tolerance Br J Pharmacol 161 5 2010 976 985
22. A.S. Adams, S.B. Soumerai, J. Lomas, and D. Ross-Degnan Evidence of self-report bias in assessing adherence to guidelines Int J Qual Health Care 11 June (3) 1999 187 192
23. M.J. DeVivo, Y. Chen, S.T. Mennemeyer, and A. Deutsch Costs of care following spinal cord injury Top Spinal Cord Inj Rehabil 16 2011 1 9
24. S. Visweswaran, and G.F. Cooper Patient-specific models for predicting the outcomes of patients with community acquired pneumonia AMIA Annual Symposium Proceedings: American Medical Informatics Association 2005 759
25. A.O. D'Souza, M.J. Smith, L.A. Miller, and J. Kavookjian An appraisal of pharmacoeconomic evidence of maintenance therapy for COPD CHEST J 129 6 2006 1693 1708